MedPath

RCT-evaluation of Retzius-sparing Robotic Prostatectomy

Not Applicable
Conditions
Urinary Incontinence
Prostate Cancer
Interventions
Procedure: robotic Prostatectomy (RARP)
Registration Number
NCT03787823
Lead Sponsor
Heidelberg University
Brief Summary

Prospective randomized blinded RCT comparing Transdouglas Prostatectomy to classical transperitoneal anterior radical prostatectomy

Detailed Description

We will evaluate functional urinary and sexual recovery, oncologic outcomes and postoperative complications in patients over a follow up period of 12 months

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
186
Inclusion Criteria
  • Indication for radical prostatectomy
  • >18 years old
  • Literate
  • Preoperatively continent
  • informed signed consent for study
Exclusion Criteria
  • cT4-Cancer
  • Withdrawl of consent to study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
anterior transperitoneal RARProbotic Prostatectomy (RARP)Arm A randomizes men with an indication for radical robotic Prostatectomy (RARP) to anterior transperitoneal RARP
Retzius-sparing RARProbotic Prostatectomy (RARP)Arm B randomizes men with an indication for radical robotic Prostatectomy (RARP) to retzius-sparing transdouglas RARP
Primary Outcome Measures
NameTimeMethod
Urinary continence1 Week after Prostatectomy

Pad use

Secondary Outcome Measures
NameTimeMethod
postoperative PSA12 months
Resection marginepathology report, approximately 1 week postoperatively
Urinary continence3, 6 and 12 months after Prostatectomy

Pad use

Postoperative complicationsFirst 12 months after Prostatectomy

Trial Locations

Locations (1)

University of Heidelberg

🇩🇪

Heidelberg, Germany

© Copyright 2025. All Rights Reserved by MedPath